Avanos Medical, Inc.
AVNS
$12.71
-$0.39-2.98%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 97.00M | 107.70M | 89.00M | 92.20M | 75.80M |
| Total Receivables | 104.80M | 132.80M | 131.90M | 123.00M | 131.30M |
| Inventory | 138.10M | 138.80M | 161.90M | 163.90M | 165.60M |
| Prepaid Expenses | 12.50M | 14.10M | 15.90M | 13.70M | 28.60M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 73.90M | 81.30M | 66.50M |
| Total Current Assets | 352.40M | 393.40M | 472.60M | 474.10M | 467.80M |
|
|
|||||
| Total Current Assets | 352.40M | 393.40M | 472.60M | 474.10M | 467.80M |
| Net Property, Plant & Equipment | 141.90M | 144.80M | 136.00M | 140.10M | 140.40M |
| Long-term Investments | 455.90M | 455.60M | 795.10M | 794.40M | 794.90M |
| Goodwill | 455.90M | 455.60M | 795.10M | 794.40M | 794.90M |
| Total Other Intangibles | 107.20M | 112.30M | 220.10M | 226.20M | 232.80M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 50.40M | 48.10M | 32.40M | 23.00M | 25.40M |
| Total Assets | 1.11B | 1.15B | 1.66B | 1.66B | 1.66B |
|
|
|||||
| Total Accounts Payable | 46.00M | 54.30M | 54.20M | 51.40M | 57.00M |
| Total Accrued Expenses | 54.90M | 73.30M | 76.50M | 73.40M | 57.60M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 19.80M | 20.30M | 23.10M | 24.60M | 20.90M |
| Total Finance Division Other Current Liabilities | 16.50M | 18.00M | 59.10M | 58.80M | 69.70M |
| Total Other Current Liabilities | 16.50M | 18.00M | 59.10M | 58.80M | 69.70M |
| Total Current Liabilities | 137.20M | 165.90M | 212.90M | 208.20M | 205.20M |
|
|
|||||
| Total Current Liabilities | 137.20M | 165.90M | 212.90M | 208.20M | 205.20M |
| Long-Term Debt | 98.00M | 125.30M | 152.60M | 164.90M | 167.20M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 23.10M | 24.60M | 26.50M | 28.80M | 26.60M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 10.10M | 9.90M | 34.50M | 33.90M | 34.40M |
| Total Liabilities | 268.40M | 325.70M | 426.50M | 435.80M | 433.40M |
|
|
|||||
| Common Stock & APIC | 1.68B | 1.68B | 1.68B | 1.67B | 1.67B |
| Retained Earnings | -700.40M | -707.00M | -309.70M | -314.00M | -315.80M |
| Treasury Stock & Other | -143.50M | -143.60M | -135.80M | -136.00M | -124.50M |
| Total Common Equity | 839.40M | 828.50M | 1.23B | 1.22B | 1.23B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 839.40M | 828.50M | 1.23B | 1.22B | 1.23B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 839.40M | 828.50M | 1.23B | 1.22B | 1.23B |
|
|
|||||